(Q46036136)

English

NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type.

scientific article published on 24 April 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19395464

NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19395464

extranodal NK/T-cell lymphoma, nasal type

0 references

1 reference

based on heuristic

inferred from title

author name string

Xueguang Liu

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19395464

Biyun Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19395464

Xuejun Ma

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19395464

Ye Guo

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19395464

publication date

24 April 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19395464

Japanese Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19395464

39

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19395464

7

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19395464

418-424

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19395464

The pathology of NK-cell lymphomas and leukemias

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

NF-kappaB regulation in the immune system

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Signaling to NF-kappaB

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Nuclear factor-kappaB in cancer development and progression

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

NF-kappaB in cancer: from innocent bystander to major culprit

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

The NF-kappaB signalling pathway: a therapeutic target in lymphoid malignancies?

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Effects of nuclear factor-kappaB inhibitors and its implication on natural killer T-cell lymphoma cells

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Nuclear factor-kappaB activation correlates with better prognosis and Akt activation in human gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Nuclear factor-kappaB inhibitors as sensitizers to anticancer drugs

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Inhibition of NF-kappaB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Enhanced chemosensitivity to irinotecan by RNA interference-mediated down-regulation of the nuclear factor-kappaB p65 subunit

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

The two NF-kappaB activation pathways and their role in innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Two pathways to NF-kappaB.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell lines

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Epstein-Barr virus-associated lymphomas.

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Nuclear Factor-kB Tumor Expression Predicts Response and Survival in Irinotecan-Refractory Metastatic Colorectal Cancer Treated With Cetuximab-Irinotecan Therapy

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Nuclear Localization of Nuclear Factor- B p65 in Primary Prostate Tumors Is Highly Predictive of Pelvic Lymph Node Metastases

1 reference

https://api.crossref.org/works/10.1093%2FJJCO%2FHYP037

21 January 2018

Identifiers

10.1093/JJCO/HYP037

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19395464

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19395464

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46036136&oldid=1667442491"